MATN3 and clear cell renal carcinoma: The same trend of worse prognosis was observed in patients with lung cancer, renal clear cell carcinoma, or hepatocellular carcinoma exhibiting low HOXB2 and/or low HOXB2/MATN3/ECM2 expression (Fig. S8e-g).